Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Bladder”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Not applicableUnknownNCT04144270
What this trial is testing

The Importance of Muscle Function in Patients With Disseminated Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasm
Rigshospitalet, Denmark 30
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Testing effectiveness (Phase 2)Study completedNCT04576286
What this trial is testing

Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder

Who this might be right for
Urinary Bladder Neoplasm
Ain Shams University 100
Not applicableStudy completedNCT03591367
What this trial is testing

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

Who this might be right for
Bladder CancerBladder DiseaseBladder Neoplasm+1 more
Mansoura University 115
Early research (Phase 1)Study completedNCT04306900
What this trial is testing

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Who this might be right for
Solid Tumor, Adult
Trishula Therapeutics, Inc. 185
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Study completedNCT02655081
What this trial is testing

Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy

Who this might be right for
Bladder Cancer
University of Pittsburgh 48
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Early research (Phase 1)Ended earlyNCT06630247
What this trial is testing

A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more
Exelixis 9
Testing effectiveness (Phase 2)Looking for participantsNCT06290687
What this trial is testing

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Who this might be right for
Malignant Neoplasm of BladderMuscle Invasive Bladder Carcinoma
Case Comprehensive Cancer Center 40
Not applicableLooking for participantsNCT06995898
What this trial is testing

The Vanguard Study: Testing a New Way to Screen for Cancer

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+8 more
National Cancer Institute (NCI) 24,000
Large-scale testing (Phase 3)Looking for participantsNCT05037279
What this trial is testing

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Who this might be right for
Bladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc. 540
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Testing effectiveness (Phase 2)Study completedNCT01684098
What this trial is testing

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Who this might be right for
Recurrent or Metastatic CancerHead and Neck CancerPancreas Cancer+2 more
Endocyte 40
Testing effectiveness (Phase 2)Study completedNCT00034593
What this trial is testing

Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Urologic Neoplasms
Eli Lilly and Company
Not applicableStudy completedNCT01446822
What this trial is testing

Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

Who this might be right for
Neoplasm of Lateral Wall of Urinary Bladder
Daniel Stephan Engeler 44
Testing effectiveness (Phase 2)UnknownNCT03560479
What this trial is testing

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Hamlet Pharma AB 52
Load More Results